Enhanced MEK activity is reported in in human breast cancers compared with benign breast tissue [33] whilst survival analysis has shown a positive correlation between elevated MAPK activity in primary breast cancers and decreased relapsed free survival [34]. This evidence concerns the gene MAP2K7 and breast carcinoma.